GAFFX | SMMIX | GAFFX / SMMIX | |
Total Expense Ratio | 0.30 | 0.83 | 36% |
Annual Report Gross Expense Ratio | 0.30 | 0.83 | 36% |
Fund Existence | 9 years | 43 years | - |
Gain YTD | 13.509 | 6.671 | 202% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 328B | 3.64B | 9,021% |
Annual Yield % from dividends | 0.61 | 0.00 | - |
Returns for 1 year | 18.19 | 21.73 | 84% |
Returns for 3 years | 59.69 | 61.36 | 97% |
Returns for 5 years | 50.79 | 24.05 | 211% |
Returns for 10 years | N/A | 79.40 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LIFLX | 15.29 | 0.14 | +0.92% |
Lord Abbett Focused Large Cap Value I | |||
FMCAX | 44.98 | 0.26 | +0.58% |
Fidelity Advisor Stock Selec Mid Cp M | |||
PRHSX | 77.94 | 0.43 | +0.55% |
T. Rowe Price Health Sciences | |||
NMULX | 11.25 | 0.04 | +0.36% |
Neuberger Berman Multi-Cap Opp I | |||
CGRNX | 32.15 | -0.12 | -0.37% |
Invesco Comstock Select R |